Screener
Aurinia Pharmaceuticals AUPH Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Deferred revenue | 10,593 | 3,720 |
| Operating lease liabilities, current portion | 1,705 | 1,067 |
| Other current liabilities | 5,269 | 2,480 |
| Total current liabilities | 99,893 | 93,724 |
| Finance lease liabilities, less current portion | 43,943 | 52,322 |
| Deferred tax benefits | 23,128 | — |
| Deferred revenue, less current portion | 7,480 | 12,648 |
| Operating lease liabilities, less current portion | 2,009 | 4,900 |
Item 1. Financial Statements.
FAQ
- What is Aurinia Pharmaceuticals's total current liabilities?
- Aurinia Pharmaceuticals (AUPH) reported total current liabilities of $99.89M in Q2 2026.
- How has Aurinia Pharmaceuticals's total current liabilities changed year-over-year?
- Aurinia Pharmaceuticals's total current liabilities increased by 27.6% year-over-year, from $78.27M to $99.89M.
- What is the long-term trend for Aurinia Pharmaceuticals's total current liabilities?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's total current liabilities has grown at a 24.0% compound annual growth rate (CAGR), from $32M to $93.72M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Aurinia Pharmaceuticals's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude